News Daily News LBBB Remains Problematic 1 Year Post-TAVI: TVT Registry Yael L. Maxwell January 07, 2026
News Daily News TAVI Patients Seem to Pay No Penalty for Obstructive CAD Yael L. Maxwell December 09, 2025
News Conference News TCT 2025 ENCIRCLE: Good Results With Sapien M3 Transseptal TMVR Todd Neale October 27, 2025
News Conference News TCT 2025 TTVR Remains Safe, Effective in Presence of CIED Leads Todd Neale October 25, 2025
News Features Imperfect Evidence: How Strong Is the Case for Transcatheter Tricuspid Valve Interventions? Todd Neale October 22, 2025
News Conference News ESC 2025 MAPLE-HCM Is a Win, ODYSSEY-HCM Isn’t: Obstructive vs Nonobstructive Divide Caitlin E. Cox August 30, 2025
News Conference News NY Valves 2025 Changes in Quality of Life Mirror TR Reductions After Tricuspid Procedures: Tri-QOL Yael L. Maxwell July 01, 2025
News Conference News NY Valves 2025 Good Outcomes, Little Hospital Experience: Pascal TEER in Real World Yael L. Maxwell June 30, 2025
News Conference News ESC Heart Failure 2025 No Additional Gain in Quality of Life With Dapagliflozin on Top of TAVI Todd Neale May 20, 2025
News Daily News Mavacamten Strikes Out in Phase III Trial of Nonobstructive HCM L.A. McKeown April 15, 2025
News Conference News ACC 2025 Tight Fluid Restriction Not Needed in Chronic HF Patients: FRESH-UP Michael O'Riordan April 01, 2025
News Conference News ACC 2025 Evolut Low Risk Trial: TAVI Holds Up to Surgery at 5 Years L.A. McKeown March 30, 2025
News Daily News Some Mitral TEER Patients Slipping Through the Cracks in the First Month Michael O'Riordan March 21, 2025
News Daily News Patient-Centric Outcomes Embraced by Global Heart Valve Experts L.A. McKeown February 24, 2025
News Conference News THT 2025 Questioning the KCCQ: Experts Debate Its Validity as QoL Metric Todd Neale February 19, 2025
News Conference News THT 2025 HF Benefits Look Durable in Single-Arm Study of Coronary Sinus Shunt Todd Neale February 18, 2025
Presentation THT 2025 Evidence That Challenges the Validity of KCCQ as a Measure of Quality of Life in Both Blinded and Unblinded Studies Presenter: Gregg Stone February 13, 2025
Presentation THT 2025 Evidence Supporting the Use of KCCQ as a Valid Measure of Quality of Life in Both Blinded and Unblinded Studies Presenter: David Cohen February 13, 2025
News Conference News THT 2025 Tirzepatide Helps in HFpEF Across Spectrum of Obesity Severity Todd Neale February 12, 2025
News Conference News AHA 2024 SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity Michael O'Riordan November 16, 2024